137
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Exploring Indian women’s perception and care seeking behavior towards lumbopelvic pain: A qualitative study

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
 

ABSTRACT

Globally, musculoskeletal lumbopelvic pain (LPP) predominates among women. This high predominance of LPP is attributed to the complex interaction of biomechanical, psychological, and social factors among women. The deleterious effect of LPP has increased the likelihood of LPP-care seeking among women. The need for care seeking is influenced by a person’s perception, beliefs, and attitude toward pain; which in turn, is framed by his/her culture and community. Thus, this qualitative research aimed to seek insights into LPP-care seeking behaviors among women from Indian cultural background. Semi-structured interviews were administered among 18 women living in urban as well as semi-urban areas of North India. Analysis of interview scripts lead to generation of three themes: LPP-care seeking behavior, non-adherence to LPP rehabilitation and barriers to LPP rehabilitation. LPP-care seeking behavior was influenced by unawareness about physiotherapy (PT), self-help practices and beliefs about LPP. We also found that lack or incomplete knowledge incite false assumptions, resulted in non-adherence in LPP rehabilitation. In addition, unsupportive family, lack of time, and difficulty in memorizing LPP exercises were the cultural, work, and old age-related barriers to LPP-care seeking, respectively.

Acknowledgments

The authors are thankful to all the women who volunteered to participate in this study and Pfizer Inc. and Eli Lilly and Company, New York, NY 10017 for funding this study.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

This study was funded by a grant program from Pfizer Inc. and Eli Lilly and Company, New York, NY 10017 55988369.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.